The short version
Aetna's coverage of GLP-1 weight-loss medications shifted in 2024 when most commercial PPO plans added Wegovy to Tier 3 and Zepbound to Tier 4 with PA. The PA criteria are standard for the category: BMI 30 or BMI 27 with comorbidity, plus six months of documented lifestyle modification or a prior anti-obesity medication trial. The hard part is the documentation, and that's where program selection matters.
What we considered
- In-network with Aetna commercial PPO
- Will run prior auth for Wegovy or Zepbound on Aetna
- Documents comorbidities (HTN, dyslipidemia, sleep apnea) correctly for PA
- Handles step-therapy paperwork if your Aetna plan requires it
Top pick: PlushCare
PlushCareInsurance-first telehealth. As low as $25/mo for Wegovy if your plan covers it.
Starts From
$19.99/mo+ medication separateLock-In
Month-to-monthScore
7.2
PlushCare is in-network with most Aetna commercial PPO plans and actively runs PA on Wegovy and Zepbound. The fastest from intake to PA submission, often within 24 hours.
Read the full PlushCare review →
Other strong picks
Form HealthForm Health's obesity-medicine specialists write the strongest PA letters, with the highest documented Aetna approval rate in the chart for step-therapy cases.
Starts From
$299/mo+ med separateLock-In
Month-to-monthScore
7.6
KnownwellKnownwell takes Aetna and handles the comorbidity documentation as part of the standard intake.
Starts From
Insurance-billed+ med separateLock-In
Month-to-monthScore
7.5
9amHealth9amHealth targets metabolic-syndrome patients where Aetna coverage is most reliable.
Starts From
$25/mo+ med separateLock-In
Month-to-monthScore
7.4
Related
Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each program's public-facing page weekly.